Detalhe da pesquisa
1.
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials
Eur. heart j;
44(11)Dec. 2022.
Artigo
em Inglês
| CONASS, SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1410953
2.
Association of pulse pressure with clinical outcomes in patients under different antiplatelet strategies after percutaneous coronary intervention: analysis of GLOBAL LEADERS
Can J Cardiol;
36(5): 747-755, May., 2020. tab., graf.
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1102329
3.
Los biomarcadores cardiacos e inflamatorios se asocian con un empeoramiento en los outcomes renales en pacientes con diabetes mellitus tipo 2: observaciones del estudio SAVOR-TIMI 53 / Cardiac and inflammatory biomarkers are associated with worsening renal outcomes in patients with type 2 diabetes mellitus: observations from SAVOR-TIMI 53
Acta bioquím. clín. latinoam;
54(1): 69-80, mar. 2020. graf, tab
Artigo
em Espanhol
| LILACS-Express
| ID: biblio-1130581
4.
Ascertainment of silent myocardial infarction in patients undergoing percutaneous coronary intervention (from the GLOBAL LEADERS Trial)
Am. j. cardiol;
124(12): 1833-1840, dez., 2019. tab., graf.
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1050065
5.
Dual antiplatelet therapy duration based on ischemic and bleeding risks after coronary stenting
J. Am. Coll. Cardiol;
73(7): 741-754, Fev. 2019. gráfico, tabela, ilustração
Artigo
em Inglês
| SES-SP, CONASS, SESSP-IDPCPROD, SES-SP | ID: biblio-1023289
6.
Rationale, design and baseline characteristics of participants in the cardiovascular outcomes for people using anticoagulation strategies (COMPASS) trial
Can J Cardiol;
33(8): 1027-1035, 2017. ilus, tab
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1061784
7.
Associations between tooth loss and prognostic biomarkers and the risk for cardiovascular events in patients with stable coronary heart disease
Int. j. cardiol;
Oct(245): 271-276, 2017.
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1063539
8.
Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting
J Am Coll Cardiol;
69(16): 2011-2022, 2017. tab, ilus
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1063633
9.
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials
Lancet;
389(10073): 1025-1034, 2017.
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1064596
10.
Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial
Lancet;
387(10014): 127-135, 2016.
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1064586
11.
Design and rationale of the TOTAL trial: A randomizedtrial of routine aspiration ThrOmbecTomy withpercutaneous coronary intervention (PCI) versus PCIALone in patients with ST-elevation myocardialinfarction undergoing primary PCI
Am. heart j;
167(03): 315-321, 2014.
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1059472
12.
Ivabradine in Stable Coronary Artery Diseasewithout Clinical Heart Failure
N. Engl. j. med;
371(12): 1091-1099, 2014.
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1064871
13.
Design and rationale of the radIal Vs. femorAL access for coronary intervention (RIVAL) trial: A randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromes
Am. heart j;
161(2): 254-260, 2011. ilus
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1059468
14.
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial
Lancet;
377(9775): 1409-1420, 2011. ilus, tab
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1064569
15.
Use of proven therapies in non-ST-elevation acute coronary syndromes according to evidence-based risk stratification / Use of proven therapies in non-ST-elevation acute coronary syndromes according to evidence-based risk stratification
Am. heart j;
153(04): 493-499, Abril 2007.
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1059462